Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 4/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 5/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.32 |
| ▸ | DPP4 | P27487 | 3/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FAP | Q12884 | 1/20 | 0.31 |
| ▸ | GCLC | P48506 | 1/20 | 0.31 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24667723 | 1.00 | SLC1A2 (0.38) | SLC1A2SLC1A1SLC1A3CA1CA2 | |
| SCHEMBL17789273 | 1.00 | SLC1A2 (0.38) | SLC1A2SLC1A1SLC1A3CA1CA2 | |
| SCHEMBL16602076 | 0.80 | SLC1A2 (0.42) | SLC1A2SLC1A1SLC1A3CA1CA2 | |
| SCHEMBL23376611 | 0.80 | SLC1A2 (0.42) | SLC1A2SLC1A1SLC1A3CA1CA2 | |
| SCHEMBL17789275 | 0.80 | SLC1A2 (0.42) | SLC1A2SLC1A1SLC1A3CA1CA2 | |
| SCHEMBL17789294 | 0.79 | SLC1A1 (0.34) | SLC1A1GRIK1ALDH1A1MAPTPTGS1 | |
| SCHEMBL15745571 | 0.79 | SLC1A1 (0.34) | SLC1A1GRIK1ALDH1A1MAPTPTGS1 | |
| SCHEMBL10037279 | 0.79 | GRIK1 (0.32) | GRIK1DPP4DPP9DPP7ALDH1A1 | |
| SCHEMBL17085295 | 0.79 | SLC1A1 (0.34) | SLC1A1GRIK1ALDH1A1MAPTPTGS1 | |
| SCHEMBL10037276 | 0.79 | GRIK1 (0.32) | GRIK1DPP4DPP9DPP7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11529422-B2 | Polymer linkers and their uses | NOVACYTE THERAPEUTICS COMPANY., LTD (CN) | 2022-12-20 | — | — | US | disclosed |
| US-20200155693-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-20190083634-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2019-03-21 | — | — | US | disclosed |
| US-20170045522-A1 | FLUORESCENT MOLECULAR SENSOR FOR TARGETING CHANGES IN PROTEIN SURFACES, AND METHODS OF USE THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-02-16 | — | — | US | disclosed |
| US-20160089446-A1 | Modified Hydrogels | ASCENDIS PHARMA A/S (DK) | 2016-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089446-A1 | Modified Hydrogels | CD44, DNPH1, PHYKPL | SLC1A2 2667/4885SLC1A1 2254/4885SLC1A3 3010/4885 |
| US-11529422-B2 | Polymer linkers and their uses | PHF2, PHF8, PAICS | SLC1A2 2112/4885SLC1A1 1066/4885SLC1A3 1241/4885 |
| US-20190083634-A1 | POLYMER LINKERS AND THEIR USES | PHF2, PHF8, PAICS | SLC1A2 2265/4885SLC1A1 1069/4885SLC1A3 1326/4885 |
| US-20200155693-A1 | POLYMER LINKERS AND THEIR USES | PHF2, PHF8, PAICS | SLC1A2 2112/4885SLC1A1 1066/4885SLC1A3 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.